Responses
Inflammatory bowel disease
Increased risk of lymphoma among inflammatory bowel disease patients treated with azathioprine and 6-mercaptopurine
Compose a Response to This Article
Other responses
Jump to comment:
- Published on: 18 April 2016
- Published on: 18 April 2016Risk of lymphoma: inflammatory bowel disease and immunomodulatorsShow More
Dear Editor,
We read with great interest the meta-analysis by Kandiel et al., (Gut 2005; 54: 1121-1125) the purpose of which was to provide a more precise estimate of the relative risk of lymphoma among inflammatory bowel disease (IBD) patients treated with azathioprine or 6-mercaptopurine (6-MP). Based on the six studies included in their meta-analysis, Kandiel et al., determined that the risk of lymphoma among...
Conflict of Interest:
None declared.